UMEM Educational Pearls

Background:  As discussed previously, influenza (flu) is a common respiratory disease that causes significant morbidity and mortality worldwide (see pearl from October 1. 2014).  We are now in the midst of the current flu season.

 

Current Update: This year’s vaccine was only a partial match (<50%) for the current influenza A (H3N2) circulating virus, so there is a significant potential for a “bad” flu season with widespread disease and severe illness.  Currently, influenza is now widespread throughout the US, with some states reporting more activity than others.  The CDC has a weekly surveillance map that highlights current disease spread.

 

Bottom Line:

  • Remember that influenza annually causes between 250,000 and 500,000 deaths worldwide.
  • Your emergency department will likely see many individuals with influenza this year, even if the patient received the vaccination.
  • Know your emergency department protocols and policies for cohorting influenza patients  and addressing droplet isolation precautions.

Show References

Attachments



How does it present?

  • Fever, cough, sore throat, runny nose, muscle aches, headaches, fatigue, diarrhea (in children especially)

Who cares…I got my vaccine! Does the vaccine work this year?

  • There has been some antigenic drift this year in the influenza A (H3N2) type virus.
  • 52% are anti-genically different than the H3N2 vaccine virus.
  • So the vaccine is less effective this year but it can give some cross-protection (in addition to protection against the other strains used in the vaccine)
  • CDC recommends still getting the vaccine  (http://www.cdc.gov/flu/protect/vaccine/vaccines.htm)
  • 91% of samples reported to the CDC have been influenza A this year

Can I test for this?

  • Rapid influenza diagnostic tests check for antigen detection
  • Pooled sensitivity of 62%; specificity of 98%
  • False negatives are common
  • Good technique during sample collection is important

The CDC is recommending treatment...wait I thought we were done with Tamiflu?

  • Benefits: shortens the duration of symptoms (day or less), reduces the risk of complications, reduces the risk of death among hospitalized patients
  • Risks: side effects (see below)
  • A recent Cochrane review revealed that treatment did not really help reduce complications and most of the data on anti-viral agents is biased (Roche funded) and hotly debated

Who is at risk/who deserves consideration for treatment?

  • Hospitalized patients with influenza 
  • Old people (>65)
  • Children
  • Pregnant women
  • Chronic medical conditions (asthma, COPD, diabetes, or heart disease)
  • American Indians and Alaskan natives
  • Chronic immunosuppression
  • Institutional outbreaks (nursing homes, correctional facilities)

Pearls of treatment

  • Treat as early as possible (<48hours from symptom onset)
  • 5 days of treatment; twice daily dosing. Wt based for children. Renally dosed.
  • Oseltamivir: used for more severe influenza cases
  • Zanamivir: 7 years or older; IV Zanamivir is currently in Phase III clinical trials

What are the side effects of anti-viral agents?

  • Don’t use zanamivir in patients w/ pulmonary disease
  • Transient neuropsychiatric events for oseltamivir
  • Nausea, vomiting, diarrhea are common both both

 

Show References



Question

A patient is intubated for respiratory failure and the post-intubation CXR is shown on the left. 30 minutes later the patient desaturates and another CXR is obtained (the one on the right). What’s the diagnosis and what should you do?

Show Answer

Show References



Not So Benign: Benign early repolarization (BER) effects in STEMI

- Benign early repolarization (BER) has been associated with increased risk of sudden cardiac death and ventricular fibrillation (VF) in patients with and without structural heart disease.

- Acute STEMI is associated with high incidence of ventricular arrhythmias and the most frequent cause of sudden cardiac death in the adult population.

- BER has been associated with arrhythmogenicity, however the prognostic importance of this ECG finding in patients with STEMI has not been well elucidated.

- In a recent prospective study of STEMI patients, BER was associated with higher rates of in-hospital ventricular arrhythmias and mortality; It is an independent predictor of long-term mortality beyond well-known other parameters. 

Show References



Title: Hirschsprung's disease

Category: Pediatrics

Posted: 12/13/2014 by Rose Chasm, MD (Updated: 11/25/2024)
Click here to contact Rose Chasm, MD

  • Irregular bowel movements and constipation are a common complaint pediatric complaint.
  • The majority of cases are functional, but providers should take extra care to rule out organic causes like Hirschsprung's disease particularly during the neonatal period. 
  • 1 in 5000 incidence, with abnormal innervation of the distal colon resulting in tonic contraction, and obstruction of feces.
  • In most cases, the agangionic segment is limited to the rectosigmoid area.
  • Symptoms usually begin in the first month of life and consist of obstuctive complications such as abdominal distension, bilious vomiting, and poor feeding.
  • Rectal examination should be done in all patients with constipation, and often reveals a narrowed high-pressure region adjacent to the anal sphincter.
  • Barium enema, anal manometry, and rectal biopsy all aid in the diagnosis.

Show References



Title: In-hospital outcomes for beta blocker use in cocaine-chest pain

Category: Toxicology

Keywords: cocaine, chest pain, beta blocker (PubMed Search)

Posted: 12/1/2014 by Bryan Hayes, PharmD (Updated: 12/11/2014)
Click here to contact Bryan Hayes, PharmD

Should beta blockers be withheld in cocaine-chest pain patients?

A new study retrospectively compared patients who received beta blockers as an inpatient to those who did not. Even though the beta blocker group had higher risk clinical characteristics, there was no difference in the composite primary end point of myocardial infarction, stroke, ventricular arrhythmia, or all-cause mortality within 24 hours of beta blocker use.

Important Limitations

The potentially dangerous interaction between beta blockers and cocaine is likely a much larger issue in patients with very recent cocaine use in the setting of a catecholamine surge. A retrospective analysis likely doesn't include those patients.

Application to Clinical Practice

While this study doesn't answer the question about beta blocker use in acute cocaine toxicity, it does provide some reassurance about the safety of beta blockers given for cocaine-related chest pain.

Show References



Title: Can we decrease CT utilization in mild TBI?

Category: Neurology

Keywords: clinical decision support, clinical decision rules, head CT, mild traumatic brain injury (PubMed Search)

Posted: 12/10/2014 by WanTsu Wendy Chang, MD
Click here to contact WanTsu Wendy Chang, MD

Does clinical decision support help reduce head CT utilization in mild traumatic brain injury related ED visits?

  • Mild traumatic brain injury (mTBI) account for approximately 1.2 million outpatient visits per year
  • Almost 1 million of these mTBI patients undergo head CT as part of their evaluation
  • Less than 6% have significant intracranial injuries that require neurosurgical intervention

Are we utilizing clinical decision rules adequately to help us appropriately select patients for CT imaging?

Can clinical decision support (CDS) help us reduce head CT utilization in mTBI related ED visits?

  • A recent study by Ip et al. reported on the use of a real-time computerized CDS in an EMR/CPOE system to provide feedback to an ordering provider on "low utility" CT's based on clinical decision rules (New Orleans Criteria, Canadian CT Head Rule, CT in Head Injury Patients Prediction Rule)
  • Over a 2 year period, 1221 of 1988 (64%) of mTBI related ED visits were associated with a head CT being performed
  • A 13.4% decrease in CT utilization was seen in the CDS intervention group (58.1% pre- vs. 50.3% post-, p=0.005)
  • A control cohort using the National Hospital Ambulatory Medical Care Survey (NHAMCS) as a representative of emergency medical care delivered in the U.S. showed no significant change in CT utilization in the same time period (73.3% pre- vs. 76.9% post-, p=0.272)

Take Home Point:

Clinical decision support may be a useful tool to help reduce CT utilization in mild TBI related ED visits.

Show References



The Critically Ill Patient with Ebola Virus Disease

  • The current outbreak of Ebola Virus Disease (EVD) is the largest ever recorded and has been declared "a public health emergency of international concern" by the WHO.
  • Pearls regarding critically ill patients within the current EVD outbreak include:
    • Clinical Features
      • Tachycardia, tachypnea, oliguria, and alterations in mental status are common and generally seen about 7-12 days after symptom onset.
      • Shock is often due to profound hypovolemia from GI losses.
      • Hemorrhage is a late finding and most often manifests as lower GIB.
    • Labs
      • Common lab abnormalities include hypokalemia, hypocalcemia, hypoalbuminemia, and lactic acidosis.
    • Treatment
      • The mainstay of treatment is aggressive fluid resuscitation and electrolyte repletion (especially potassium).
      • Blood products can be administered for those with coagulopathy and hemorrhage.
      • Empiric antibiotics and antimalarial medications should be considered while awaiting confirmatory testing for EVD.

Show References



Question

Patient was found in a house fire and was given a certain medication in the Emergency Room. The patient’s urine turned this color (red), what’s the diagnosis?

Show Answer

Show References



Predictors of Cardiac Rupture After AMI

- In the era of revascularization and aggressive cardiac care there has been a continual decline in acute myocardial infarction (AMI) mortality rates; however one of the most deadly complications, cardiac rupture (left ventricular free wall, ventricular septum, or papillary muscle rupture), still remains relatively stable.

- Cardiac rupture is an increasingly more frequent cause of death during AMI, thus a recent study retrospectively assessed the clinical and morphologic variables in those with and without cardiac rupture that were hospitalized for AMI.

- Cardiac rupture overwhelmingly complicates a first AMI.

- Cardiac rupture occurs most often in patients with an immense quantity of cardiac adipose tissue, the size of the left ventricular cavity is typically normal, and the area of the infarct is small.

- Heart failure patients with prior AMI have healed scar tissue and are at nominal risk of complications such as rupture if a subsequent AMI occurs.  

Show References



Many of the oral antibiotics prescribed in the ED have good bioavailability. So, a one-time IV dose before discharge generally won't provide much benefit.

In fact, a new prospective study found that a one-time IV antibiotic dose before ED discharge was associated with higher rates of antibiotic-associated diarrhea and Clostridium difficile infection. [1] One-time doses of vancomycin for SSTI before ED discharge are also not recommended (see Academic Life in EM post).

Bottom Line

Though there are a few exceptions, if a patient has a working gut, an IV dose of antibiotics before ED discharge is generally not recommended and may cause increased adverse effects. An oral dose is just fine. 

Show References



Title: Rhabdo Prevalence

Category: Toxicology

Keywords: Sympathomimetic toxicity, Synthetic cathinones, Rhabdomyolysis (PubMed Search)

Posted: 12/4/2014 by Kishan Kapadia, DO
Click here to contact Kishan Kapadia, DO

Sympathomimetic toxicity is a known toxidrome that is complicated by the development of rhabdomyolysis.  There are multiple stimulant agents that induce sympathomimetic toxicity including, synthetic cathinones, cocaine, amphetamines, and methamphetamines.  

A recent retrospective, single-center, chart review in the age range of 14-65 years sought to determine the prevalence of rhabdomyolysis in patients with sympathomimetic toxicity and compare rates among patients using specific agents.  Rhabdomyolysis and severe rhabdomyolysis were defined as CK>1000 and 10,000 IU/L, respectively.

Rhabdomyolysis occurred in 42% of study subjects (43/102)

Prevalence in 89 subjects due to a single-stimulant exposure:

Rhabdomyolysis 

1) Synthetic cathinone (MDPV, alpha-PVP) 63% (12/19)

2) Methamphetamine 40% (22/55)

3) Cocaine 33% (3/9)

4) Other single agents (methylphenidate, pseudoephedrine, phentermine) 0% (0/6)

Severe Rhabdomyolysis

1) Synthetic cathinone 26% (5/19)

2) Methamphetamine 3.6% (2/55)

3) Cocaine 11% (1/9)

4) Other single agents (methylphenidate, pseudoephedrine, phentermine) 0% (0/6)

In this study, patients exposed to synthetic cathinones were more likely to develop rhabdomyolysis and severe rhabdomyolysis compared to the non-cathinone-exposed group.

Bottom Line:

Be aware of this increased risk from synthetic cathinones along with other stimulants.  Treat aggressively with IV fluids, rapid correction of hyperthermia, benzodiazepines to control manifestations of sympathomimetic toxicity to reduce muscle activity and metabolic demand.

 

Show References



Title: Global Health and Emergency Care Research

Category: International EM

Keywords: Global Health, emergency care, acute care, research (PubMed Search)

Posted: 12/3/2014 by Jon Mark Hirshon, PhD, MPH, MD
Click here to contact Jon Mark Hirshon, PhD, MPH, MD

In December 2013, Academic Emergency Medicine published the results of the 2013 consensus conference that focused on advancing global health and emergency care research.

 

As noted in the issue’s executive summary, “Emergency physicians are uniquely poised to address challenges in health services, health care systems development and management, and emerging global disease burdens (both communicable and noncommunicable). “

 

The consensus conference covered developing research in eight focus areas, including understanding of cardiac and injury resuscitation, ethics of research, health systems development, and the education of future global health leaders.

 

For anyone interested in global health and emergency care, this issue of Academic Emergency Medicine is an outstanding resource and roadmap to developing research. It can be found at: http://onlinelibrary.wiley.com/doi/10.1111/acem.2013.20.issue-12/issuetoc



 

Dynamic Measures of Intravascular Volume Assessment

The resuscitation of a patient in shock often requires the administration of intravenous fluid.  Excessive fluid resuscitation can lead to worsening pulmonary edema, systemic edema, acid-base disturbances, as well as many other complications. There are a myriad of techniques to try and figure out if the patient needs more intravascular volume, but each has it’s pitfalls.

Recently, experts have recommend that we move away from using static measures of preload assessment such as central venous pressure (CVP) and instead focus on using dynamic measures for volume responsiveness.

Volume Responsiveness Defined: An increase of stroke volume of 10-15% after a 500 mL IV crystalloid bolus over 10-15 minutes.

Below is a chart describing key values, requirements, and contraindications for each of these dynamic measures of non-invasive intravascular volume assessment. 

Important notes:  PPV and SVV require the patient to be intubated with controlled tidal volumes.  Arrhythmias and right heart failure make many of these measures invalid (except for PLR).  Other methods of assessment not discussed include systolic pressure variation, left ventricular outflow track velocity time integral (LVOT VTI), and end-expiratory occlusion pressure (EEO).

Bottom Line: None of these measures are perfect and shouldn't be used in isolation to determine if the patient’s “tank is full”.  Combine clinical judgment with these measures to get a best estimate of whether or not to give that next fluid bolus.  

 

Reference

1. Enomoto TM, Harder L. Dynamic indices of preload. Crit Care Clin. 2010;26(2):307-21, 

Follow Me on Twitter @JohnGreenwoodMD



Question

Patient presents with dyspnea. What's the diagnosis and name three potential causes (can be specific to the case or in general)?

Show Answer

Show References



A recent meta-analysis of 14 studies looked at the typical red flags of back pain to see which ones actually truly increase the risk that the patient will have a fracture or malignancy.


The typical historical red flags that are taught are

  • Age under 18 or over 50
  • Pain lasting more than 6 weeks
  • History of cancer
  • Fever and chills
  • Night sweats, unexplained weight loss
  • Recent bacterial infection
  • Unremitting pain despite rest and analgesics
  • Night pain
  • Intravenous drug users
  • Immunocompromised
  • Major trauma
  • Minor trauma in the elderly


And physical exam red flags are

  • Fever
  • Writhing in pain
  • Bowel or bladder incontinence
  • Saddle anesthesia
  • Decreased or absent anal sphincter tone
  • Perianal or perineal sensory loss
  • Severe or progressive neurologic defect
  • Major motor weakness


However, this meta-analysis showed that the only red flags that actually increased the risk of fracture or malignancy were

  • Older Age  Post test Probability 9% (95% CI 3% to 25%)
  • Prolonged corticosteroid use Post test Probability 33% (95% CI 10% to 67%)
  • Severe trauma Post test Probability 11% (95% CI 8 % to 16%)
  • Presence of contusion or abrasion Post test Probability 62% (95% CI 49% to 74%)


So this study highlights that a lot of the red flags that we have learned do not actually increase the risk fracture or malignancy, although some like fever, IVDA, and immunocomproromised increase the risk of epidural abscesses, which was not addressed in this meta-analysis.

The take home point for me is that plain radiographs/CT scans are probably only needed in patients with older age, prolonged corticosteroid use, severe trauma or presence o contusion or abrasion. If you are really worried about others with back pain just proceed directly to MRI as the plain films/CT scans are not going to be very helpful.
 

Show References



Dehydration is a common pediatric ED presentation. Oral rehydration (although first choice) is often not possible secondary to patient cooperation and/ or persistent vomiting. Intravenous (IV) hydration is often difficult, requiring multiple attempts especially in the young dehydrated infant.

Hyaluronan is a mucopolysaccharude present in connective tissue that prevents the spread of substances through the subcutneous space. Hyaluronidase is a human DNA-derived enzyme that breaks down hyaluronan and temporarily increases its permeability, thereby allowing fluid to be absorbed with the capillary and lymphatic systems.

In one study, patients age 1 month to 10 years were randomized to recieve 20 mL/kg bolus NS via subcutaneous (SC) or IV route over one hour, then as needed. The mean volume infused in the ED was 334.3 mL (SC) vs 299.6 mL (IV). Succesful line placement occured in all 73 SC patients and only 59/75 IV patients. There was a higher proportion of satisfaction for clinicians and parents for ease of use and satisfaction, respectively.

Bottom line: Consider subcutaneous hyaluronidase faciliated rehydration in mild to moderately dehydrated children, especially with difficult IV access.

Show References



Title: Identification of cyanide poisoning in smoke inhalation victims.

Category: Toxicology

Keywords: Cyanide, smoke inhalation, lactate (PubMed Search)

Posted: 11/28/2014 by Hong Kim, MD (Updated: 11/25/2024)
Click here to contact Hong Kim, MD

Cyanide poisoning is rare but highly lethal. Cyanide exposure can occur during residential fire (most common source of exposure) where combustion of synthetic materials (i.e. plastic and polyurethane) releases cyanide gas as well as other toxic gases, including carbon monoxide. Although carbon monoxide poisoning can be readily identified by CO-Hb level using CO-oximetry, serum/blood cyanide level is not readily available for acute management.

 

However, elevated lactate level (> 10 mmol/L ) has shown to be highly correlated with toxic level of cyanide (40 micromol/L or 1 mg/L) in smoke inhalation victims (Baude FJ et al. N Engl J Med 1991;325:1761-6).

  • Sensitivity: 87%
  • Specificity: 94%
  • Positive predictive value: 95%

 

Bottom line: when managing smoke inhalation victims, think about cyanide poisoning in addition to carbon monoxide poisoning and check the lactate level. Lactate > 10 mmol/L is suggestive of cyanide poisoning and should be treated with hydroxocobalamin. 

Show References



Title: Visual Loss in Idiopathic Intracranial Hypertension

Category: Neurology

Keywords: pseudotumor cerebri, visual loss, shunt (PubMed Search)

Posted: 11/27/2014 by Danya Khoujah, MBBS
Click here to contact Danya Khoujah, MBBS

There are a few available options for treatment of visual loss due to idiopathic intracranial hypertension (IIH). The Idiopathic Intracranial Hypertension Treatment Trial (IIHTT), the first randomized, prospective, placebo-controlled trial for the treatment of patients with visual loss from IIH, which results were published earlier this year, provided substantial evidence for the first 2 options.

1. Weight loss

2. Carbonic anhydrase inhibitors, such as Acetazolamide

3. Therapeutic lumbar puncture (reserved for pregnant patients or for occasional flare-ups)

4. Surgery:

a. Optic nerve sheath fenestration (ONSF): visual acuity and fields improve in most cases, but symptoms may recur. Benefit? No hardware!

b. Shunts: ventriculoperitoneal (VP) and lumboperitoneal (LP) shunts are the most frequently used. No clear benefit for one over the other. VP shunts may be programmable.

c. Cerebral venous stenting: endovascular stenting of the transverse sinus may improve the symptoms in some people.

BONUS PEARL: The headache does not correlate with the lumbar opening pressure, degree of papilledema or amount of visual loss. None of the above-mentioned management strategies is meant for the treatment of the headache alone. For that, medical management with standard symptomatic treatments, avoiding opiates and barbiturates, is recommended. Surgery is not recommended for headache alone.

Show References



Running a successful resuscitation not only means doing everything right, but also remembering all the things that can go wrong. A.E.I.O.U. is a simple mnemonic that can help you remember the simple things that are sometimes forgotten during a medical resuscitation.

AAdvanced airway equipment to bedside, as well as checking the correct placement of the Airway if a patient is intubated in the field. Also consider adding another A, for Arterial line; early placement can help with pulse checks and an accurate assessment of blood pressure should there be return of spontaneous circulation (ROSC); the femoral site is fast and accurate.

EEnd-tidal CO2 (ETCO2) helps detect ROSC. Ask for the ETCO2 monitor to be set up right after you receive notification of an arrest in transit; ETCO2 requires time to set-up / calibrate

IIntraosseous line(s); compared to peripheral or central venous access, IO’s are faster, safer, and any medication can be administered through it, including vasopressors / inotropes.

OOrder (i.e., “who’s who in the Resus room?); You may be the team leader or you may be assisting, but it is important that you, and everyone else in the room, know their role prior patient arrival. If you are leading the resus, be sure everyone knows who you are, and assign everyone in the room a specific task (e.g., chest compressions, IO placement, etc.). If you are assisting and have not been assigned a task, ask the resus leader what you can do to help. If there is nothing immediate for you to do then take the initiative to de-clutter the room and step outside; be nearby and ready to help, if needed.

UUltrasound; can help prognosticate and detect reversible causes (e.g., pericardial tamponade). Have the ultrasound machine in the room prior to patient arrival. It should be powered on, with the proper probe connected, and in the proper mode. The most experienced ultrasonographer should scan the patient during a pulse check; experience is vital because hands-off time should be minimized.

 

*Tips for the Resuscitationist (#TFTR) is a new series to help you to better manage your critically ill patients. Do you have an idea for a topic or do you have a tip you would like to share? Send it to us via twitter @criticalcarenow (use (#TFTR)). You can also email us here

Show References